2m 2m 2m 2m 2m 2m 2m
ACURX PHARM (ACXP)
NASDAQ
$1.50+$0.06 (+3.82%)
Price as of Aug 03, 2026 9:01 AM EDT- $6.2MMarket Cap
- -76.55%1-Year Change
- BiotechnologyIndustry
ACURX PHARM (ACXP)
$1.50+$0.06 (+3.82%)
ACXP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.44 | ||
Change | +$0.02 (+1.41%) | ||
Open | $1.44 | ||
High | $1.44 | ||
Low | $1.38 | ||
Previous Close | $1.42 | ||
Volume | 27,410 | ||
30-Day Average Volume | 91,678 | ||
1-Week Change | 1.41% | ||
1-Month Change | -7.10% | ||
1-Year Change | -76.55% | ||
3-Year Change | -96.45% | ||
5-Year Change | -98.73% | ||
Fundamentals | |||
Shares Outstanding | 4.3M | ||
Total Assets | $9.5M | ||
Market Cap | $6.2M | ||
Enterprise Value | -$3.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$1.7M | ||
Free Cash Flow | -$1.5M | ||
EBIT | -$1.7M | ||
EBITDA | -$1.7M | ||
Net Working Capital | $7.0M | ||
EPS | -$0.62 | ||
Enterprise Value/EBITDA | 2 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -2 | ||
PEG | 0 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 08/05/2025 | ||
Earnings & Revenue